Intermedin 1–53 in central nervous system elevates arterial blood pressure in rats

Abstract

Intermedin (IMD) is a novel member of the calcitonin/calcitonin gene-related peptide (CGRP) family identified from human and other vertebrate tissues. Preprointermedin can generate various mature peptides by proteolytic cleavage. Amino acid sequence analysis showed cleavage sites located between two basic amino acids at Arg93–Arg94 resulting in the production of prepro-IMD 95–147, namely IMD 1–53. The present study was designed to determine the effects of the IMD 1–53 fragment in the central nervous system (CNS) on mean arterial blood pressure and heart rate in normal rats and its possible mechanism. Rats were given doses of adrenomedullin (ADM) or IMD 1–53, intracerebroventricularly or intravenously, respectively, with continuous blood pressure and heart rate monitoring for 45 min. Analysis with CGRP receptor antagonist CGRP 8–37, ADM receptor antagonist ADM 22–52, and anti-prepro-IMD antibody showed that 0.1, 0.5, and 1.0 nmol/kg IMD 1–53, caused a dose-dependent elevation in blood pressure, which was more prominent than the increase with equivalent IMD 1–47 or ADM. As well, IMD 1–53 caused a persistent increase in heart rate. The CNS action of IMD 1–53 could be blocked by ADM 22–52, CGRP 8–37, or prepro-IMD antibody. In contrast to the CNS action, intravenous administration of IMD 1–53 induced a depressor effect. These results suggest that IMD 1–53 is an important regulatory factor in mean arterial blood pressure and heart rate through its central and peripheral bioaction.